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Surgery is an invasive procedure evoking acute inflammatory and immune responses that can influence 
risk for postoperative complications including cognitive dysfunction and delirium. Although the 
specific mechanisms driving these responses have not been well-characterized, they are hypothesized 
to involve the epigenetic regulation of gene expression. We quantified genome-wide levels of DNA 
methylation in peripheral blood mononuclear cells (PBMCs) longitudinally collected from a cohort of 
elderly patients undergoing major surgery, comparing samples collected at baseline to those collected 
immediately post-operatively and at discharge from hospital. We identified acute changes in measured 
DNA methylation at sites annotated to immune system genes, paralleling changes in serum-levels of 
markers including C-reactive protein (CRP) and Interleukin 6 (IL-6) measured in the same individuals. 
Many of the observed changes in measured DNA methylation were consistent across different types 
of major surgery, although there was notable heterogeneity between surgery types at certain loci. 
The acute changes in measured DNA methylation induced by surgery are relatively stable in the post-
operative period, generally persisting until discharge from hospital. Our results highlight the dramatic 
alterations in gene regulation induced by invasive surgery, primarily reflecting upregulation of the 
immune system in response to trauma, wound healing and anaesthesia.
Surgery is an invasive procedure that elicits dramatic challenges to normal regulatory and homeostatic processes 
in the body. Importantly, surgery evokes acute inflammatory and immunological responses, which result directly 
from the trauma of surgery itself that acts to modulate wound healing and other physiological pathways1–3. Of 
note, changes to the immunological milieu following major surgery are thought to mediate risk for a number 
of postoperative complications including nosocomial infections4, and postoperative cognitive dysfunction and 
delirium5.
Post-operatively the immune system acts to promote tissue regeneration by influencing signal transduction, 
cell migration, differentiation, proliferation, and tissue remodelling6,7. Although the specific mechanisms driving 
these responses have not been well-characterized, they are hypothesized to involve the epigenetic regulation of 
gene expression8. Epigenetic processes act to dynamically control transcription via modifications to DNA, histone 
proteins, and chromatin acting independently of DNA sequence variation, and are known to regulate the function 
of immune cells during health and disease9. Of note, changes in DNA methylation have been reported to mediate 
postsurgical pain sensitivity10 and response to anaesthesia11,12 and opioids13,14.
In this study we explored the hypothesis that immunological modulation following surgery is associated with 
acute changes in DNA methylation. We longitudinally profiled DNA methylation in PBMCs collected from a 
cohort of elderly patients undergoing different types of major surgery at three time-points. Our study identifies 
dramatic shifts in DNA methylation in the vicinity of genes involved in immune regulation, with these changes 
being relatively stable across the post-operative period.
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Results
Methodological overview. Using a longitudinal study design, we quantified DNA methylation across the 
genome in a cohort of 30 elderly patients (average age = 77.9 years (range 62–91)) undergoing major surgery 
(either elective colorectal surgery, elective hip replacement surgery, and emergency hip surgery following frac-
ture). From each individual, detailed clinical blood measures were collected and DNA methylation was profiled 
using the Illumina Human Methylation 450 array (“450 K array”) (Illumina Inc. San Diego, California) in DNA 
samples isolated from PBMCs collected at three time-points: (i) immediately before surgery (baseline (BL)), (ii) 
in the morning of post-operative day 1 (POD1) and (iii) between post-operative day 4 and 7 (POD4/7) prior to 
discharge from hospital. Our analyses focused on identifying differentially methylated positions (DMPs) and 
regions (DMRs) reflecting acute changes induced by major surgery (see Methods). An overview of the study 
design and sampling strategy is given in Supplementary Fig. S1 and details about the individual patients included 
in this study are presented in Table 1.
Major surgery is associated with acute changes in DNA methylation, primarily at sites anno-
tated to immune system genes. We first examined acute changes in DNA methylation following major 
surgery, comparing baseline PBMC samples to those at POD1, collected an average of 18.1 ± 3.2 hours after sur-
gery. In total, we identified 88 DMPs passing an experiment-wide significance threshold (P < 2.0E-07), with 5,655 
DMPs passing a more relaxed “discovery” significance threshold (P < 5.0E-05) that was used to select genes for 
subsequent gene ontology (GO) pathway analyses (Supplementary Fig. S2 and Supplementary Table S1). The top 
ranked DMP (cg15412772), which was significantly hypomethylated following major surgery (DNA methyla-
tion change = −4.23%, P = 8.08E-10), is located on chromosome 17 approximately 4 kb downstream of CSF3, 
which encodes a granulocyte colony-stimulating factor that acts to stimulate granulopoiesis and works against 
neutropenia15. We used comb-p to identify spatially-correlated regions of differential DNA methylation, iden-
tifying 913 surgery-associated DMRs (Supplementary Table S2) (Sidak-corrected P < 0.05)16. The top-ranked 
DMR spans 1,212 bp, incorporating 19 DNA methylation sites on chromosome 6 (P = 2.58E-26), overlapping 
the transcription start site (TSS) of the gene encoding lymphotoxin-A (LTA), which has an important role in 
regulating the immune system17. GO term enrichment analysis on genes annotated to the “discovery” DMPs 
highlighted a highly-significant enrichment for functional pathways associated with immune function amongst 
surgery-induced DMPs, including categories such as “immune system process” (P = 9.51E-24), “response to 
wounding” (P = 1.17E-19) and “positive regulation of immune response” (P = 4.50E-12) (Supplementary Table S3). 
To explore further the acute immune response following major surgery we measured blood serum levels of 
C-reactive protein (CRP) and Interleukin 6 (IL-6) in the same samples; CRP is an acute phase protein that rises 
in response to inflammation through hepatic synthesis in response to IL-6, a pro-inflammatory cytokine that 
is synthesised at the site of injury18,19. Compared to baseline we observed a highly significant increase in both 
serum CRP (baseline: median CRP = 6.0 mg/l; POD1: median CRP = 52 mg/l, P = 4.55E-03) (Fig. 1A) and IL-6 
(baseline: median IL-6 = 6.6 pg/ml; POD1: median IL-6 = 121.7 pg/ml, P = 7.23E-06) (Fig. 1B) at POD1. Of note, 
a recent study described an inflammation-related epigenetic polygenic score based on an analysis of variable DNA 
methylation associated with CRP in two large population-based cohorts20. We applied this predictor to our data, 
finding a significant increase in the inflammation-related polyepigenetic score at POD1 compared to baseline 
(P = 2.7E-04, Supplementary Fig. S3), providing further evidence for acute upregulation of the immune system 
following major surgery. Finally, we assessed whether major surgery is associated with two epigenetic biomarkers 
of age - the Horvath multi-tissue DNA methylation clock21 and the GrimAge clock22 that is hypothesized to more 
accurately index accelerated biological ageing. Estimates from both clocks were associated with actual chronolog-
ical age at BL (multi-tissue clock: corr = 0.57, P = 5.81E-04; GrimAge clock: corr = 0.79, P = 1.67E-07). Although 
there was no significant change in estimates derived from the multi-tissue clock following surgery, there was a 
significant increase in GrimAge detectable one day following surgery (mean change in GrimAge = 1.64 years, 
P = 2.57E-04, Supplementary Fig. S4), with this elevation being particularly pronounced in patients undergoing 
acute hip fracture surgery. Of note, previous studies have shown that accelerated GrimAge is associated with 
inflammatory conditions and an age-related decline in immune system functioning22.
Variables All Colorectal Hip Elective Hip Fracture P
Number of Subjects 30 11 10 9 —
Age 77.9 ± 6.4 73.6 ± 5.8 79.4 ± 4.6 81.3 ± 6.4 1.24E-02
Sex (M:F) 13: 17 7: 4 4: 6 2: 7 —
Smoking (Never: Ex: Current) 20: 10: 0 8: 3: 0 5: 5: 0 7: 2: 0 —
Katz index of ADL 11.9 ± 0.5 12 ± 0 12 ± 0 11.7 ± 0.9 3.22E-01
Charlson’s comorbidity score 1.7 ± 1.3 2.0 ± 1.3 1.9 ± 1.2 1.2 ± 1.3 3.69E-01
ASA class (1–2: 3–4) 23: 7 9: 2 8: 2 6: 3 —
Surgery time (hr) 2.2 ± 1.1 3.0 ± 1.0 1.4 ± 0.5 2.0 ± 1.1 1.13E-02
Anaesthesia time (hr) 2.9 ± 1.1 3.7 ± 1.1 2.3 ± 0.7 2.8 ± 1.1 1.62E-03
Time to POD1 sample (hr) 18.1 ± 3.2 17.4 ± 3.3 20.0 ± 2.6 16.9 ± 3.0 6.35E-02
Time to POD4/7 sample (days) 4.8 ± 1.0 5.5 ± 1.2 4.2 ± 0.4 4.6 ± 0.7 4.24E-03
Table 1. An overview of the surgical patients enrolled in this study. ADL = activity of daily life. 
ASA = American Society of Anaesthesiologists. Number or average ± standard deviation is shown for each 
variable.
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Although major surgery is associated with notable shifts in cell-type proportions, many 
surgery-associated changes in DNA methylation are independent of blood cell heterogene-
ity. Given the highly-significant enrichment of surgery-associated DMPs in the vicinity of genes involved in 
immune function and cell proliferation, the dramatic surgery-induced changes in CRP and IL-6, and the large 
observed differences in blood cell proportions and plasma proteins following surgery (Supplementary Figs. S5, 
S6 and Supplementary Table S4), it is important to control for variable cell populations in our DNA methylation 
analysis. Although our DNA methylation analyses were performed on PBMC samples depleted for granulocytes, 
we next used an established deconvolution algorithm to derive blood cell-type proportion estimates from our 
PBMC DNA methylation data (see Methods), identifying significant acute increases following surgery (between 
baseline and POD1) in estimates of plasmablasts (P = 2.28E-02) and monocytes (P = 4.43E-05), and significant 
decreases in naïve CD8 T cells (P = 4.96E-02), CD8 T cells (P = 1.22E-02), CD4 T cells (P = 1.19E-03), and nat-
ural killer cells (P = 5.97E-03) (see Supplementary Table S5)21. As expected, the estimated level of granulocytes 
in our isolated PBMCs was very low (mean (±SD) granulocyte proportion = 0.0129 (±0.028)). For the majority 
of samples we were able to also empirically measure actual blood cell counts; although the specific cell-types 
derived from DNA methylation data do not overlap entirely with those measured in whole blood, we observed a 
highly significant correlation between empirically-measured and estimated ratio of lymphocytes and monocytes 
(r = 0.713, P = 8.53E-15, Supplementary Fig. S7), indicating that the derived cell proportion estimates are likely 
Figure 1. Surgery is associated with acute increases in markers of inflammation. Shown are levels of serum 
C-reactive protein (CRP) and Interleukin-6 (IL-6) at baseline and after surgery. Both serum CRP (A) and IL-6 
(B) are significantly elevated at POD1 following major surgery (CRP; P = 4.55E-03, IL-6; P = 7.23E-06). Colors 
denote surgery type: colorectal surgery = red, hip elective surgery = blue, and hip fracture surgery = green.
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to reflect actual levels in our samples. These shifts in cell-type proportions are themselves interesting, reflecting 
known surgery-related immune outcomes; for example previous studies have highlighted a dramatic increase and 
upregulation of monocytes in the inflammatory response following surgery23 with lymphocytes decreasing in a 
cell-subtype specific manner24. Because such cellular changes might confound our DNA methylation analyses, we 
used a multi-level regression model including the estimated proportions of plasmablasts, CD8 + CD28-CD45RA- 
T cells, naive CD8 T cells, CD4T cells, natural killer cells and monocytes for each sample (derived from the DNA 
methylation data), in addition to age and sex, to further explore acute surgery-associated DMPs between baseline 
and POD1 (see Methods). Although there was a strong correlation for both effect sizes (r = 0.955, P = 2.20E-47, 
Supplementary Fig. S8) and P values (r = 0.621, P = 6.45E-11, Supplementary Fig. S9) between models for DMPs 
identified in our uncorrected model, the cell-proportion-corrected model identified a smaller number of signifi-
cant surgery-associated changes. In total, we identified 11 DMPs passing an experiment-wide significance thresh-
old P < 2.0E-07 (Fig. 2A and Table 2) and 475 DMPs passing a more relaxed “discovery” significance threshold 
(P < 5.0E-05) (Supplementary Fig. S10 and Supplementary Table S6). The top ranked DMP (cg26022992), which 
was significantly hypermethylated following major surgery (DNA methylation change = 2.04%, P = 1.02E-08), 
is located on chromosome 1 in the 5′ untranslated region of RBM8A, a gene encoding a protein with a conserved 
RNA-binding motif that is involved in splicing. We again used comb-p16 to identify spatially-correlated regions 
of differential DNA methylation, with the top-ranked DMR spanning nine hypomethylated sites on chromo-
some 7 immediately upstream of PON3, a member of the paraoxonase family that associates with high-density 
Figure 2. Differentially methylated positions (DMPs) associated with major surgery. (A) 11 DMPs passed our 
experiment-wide significance threshold at POD1 (P < 2.0E-07). Results for each of these sites is given in Table 2. 
(B) 43 DMPs passed our experiment-wide significance threshold at POD4/7 (P < 2.0E-07). Results for each 
of these sites is given in Table 3. There was a strong correlation of changes observed at POD1 and POD4/7 for 
DMPs identified at both time-points: (C) POD1 DMPs: corr = 0.925, P = 2.86E-05; (D) POD4/7 DMPs: corr = 
0.745, P = 6.00E-09.
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lipoprotein and has anti-inflammatory and anti-oxidant properties25 (Sidak-corrected P = 1.43E-4) (Fig. 3A 
and Supplementary Table S7). GO term enrichment analysis of genes annotated to the list of ‘discovery’ DMPs 
again highlighted a significant enrichment for functional pathways associated with immune function amongst 
surgery-induced DMPs, for example “response to interleukin-15” (P = 3.44E-10), in addition to some more phys-
iological pathways including “regulation of muscle adaptation” (P = 5.23E-06) and “respiratory system process” 
(P = 5.91E-05) (Supplementary Table S8). Finally, we explored whether within-individual changes in DNA 
methylation were associated with shifts in serum IL-6 levels following major surgery. We identified 43 sites at 
which altered DNA methylation was associated with the magnitude of change in serum IL-6 levels (P < 2.0E-07, 
Supplementary Table S9), with the top-ranked site (cg24327971) annotated to MRPL3, a mitochondrial ribosomal 
protein located on chromosome 3 (DNA methylation change per 10 pg/ml IL-6 = 0.15%, P = 4.32E-10).
Surgery-associated shifts in DNA methylation regulating the immune response are relatively 
stable until discharge from hospital. We next extended our analysis to characterize more long-term 
changes in immune response markers and DNA methylation following major surgery (i.e. those occur-
ring between BL and POD4/7), exploring the stability of acute surgery-induced changes identified at POD1. 
Compared to baseline we again observed a highly significant increase in serum CRP at POD4/7 (baseline: 
median CRP = 6.0 mg/l; POD4/7: median CRP = 66.5 mg/l, P = 1.39E-03) (Fig. 1A), with no significant change 
between POD1 and POD4/7 (P = 7.25E-01). We also found a significant increase in the inflammation-related 
polyepigenetic score derived from our DNA methylation data20 at POD4/7 compared to baseline (P = 3.3E-4, 
Supplementary Fig. S3), again with no significant change between POD1 and POD4/7 (P = 6.54E-01). In contrast, 
after peaking at POD1, levels of IL-6 returned back to baseline levels by POD4/7; interestingly IL-6 is known to 
drive the initial inflammatory response, increasing CRP via interaction with STAT26 before rapidly returning back 
to normal levels. Over the perioperative period (including samples collected at BL, POD1, and POD4/7) both 
serum CRP (corr = 0.32, P = 7.16E-03) and IL-6 (corr = 0.23, P = 1.84E-02) were found to be positively corre-
lated with the inflammation-related polyepigenetic score (Supplementary Fig. S3), although the changes in this 
predictor more closely reflect CRP than IL-6. In total we identified 43 DMPs characterized by an experiment-wide 
significant difference (P < 2.0E-07) at POD4/7 compared to BL using a model correcting for derived blood 
cell-type proportions (Fig. 2B and Table 3), with 909 DMPs identified at a more relaxed “discovery” significance 
DMP Position
GREAT 
annotation
Surgery type
All (n = 30) Colorectal (n = 11) Hip Elective (n = 10) Hip Fracture (n = 9)
BL 
DNAm 
(%)
DNAm 
change 
(%) P value
BL 
DNAm 
(%)
DNAm 
change 
(%) P value
BL 
DNAm 
(%)
DNAm 
change 
(%) P value
BL 
DNAm 
(%)
DNAm 
change 
(%) P value
cg26022992 chr1:145507616 RBM8A (+60) 8.24 2.04 1.02E-08 8.21 1.19 3.45E-03 8.62 2.14 4.68E-06 7.87 3.05 3.69E-08
cg06544731 chr1:24738219 NIPAL3 (−4025) 67.97 3.81 3.50E-08 66.68 4.38 3.54E-06 68.45 4.09 5.03E-05 69.01 1.95 7.19E-02
cg09060469 chr1:204912595
CNTN2 
(−99744), 
NFASC 
(+114814)
78.73 2.38 3.66E-08 79.29 1.84 6.90E-04 78.38 2.85 7.29E-06 78.42 2.82 5.64E-05
cg25715328 chr19:9649297 ZNF426 (+5) 4.52 −0.78 4.49E-08 4.86 −0.62 7.12E-04 4.23 −0.88 2.12E-05 4.43 −0.85 2.30E-04
cg17176946 chr11:108811287
C11orf87 
(−481558), 
DDX10 
(+275472)
87.11 −1.98 5.13E-08 87.00 −1.68 5.35E-04 87.13 −1.94 2.60E-04 87.20 −2.66 1.68E-05
cg26426898 chr20:709094
SCRT2 
(−52272), 
C20orf54 
(+40133)
40.41 −2.72 7.15E-08 41.28 −3.01 1.63E-05 39.28 −2.06 4.65E-03 40.60 −2.71 1.17E-03
cg09670701 chr15:34876396
GOLGA8B 
(−48175), 
GJD2 
(+170292)
5.72 0.83 8.19E-08 5.68 0.96 9.40E-06 5.72 0.71 1.72E-03 5.78 0.79 1.94E-03
cg01738412 chr7:87505461
DBF4 (−82), 
SLC25A40 
(+230)
4.94 −0.66 1.26E-07 5.20 −0.81 3.52E-06 4.84 −0.62 6.70E-04 4.74 −0.37 6.10E-02
cg10725932 chr11:71934276 INPPL1 (−1605) 5.94 −0.88 1.27E-07 5.72 −0.53 1.29E-02 6.05 −1.27 6.36E-07 6.10 −1.00 2.53E-04
cg15708373 chr8:81397789 ZBTB10 (−658) 4.42 0.75 1.39E-07 4.36 0.86 1.31E-05 4.39 0.73 5.08E-04 4.54 0.69 3.42E-03
cg08174577 chr2:52007582 NRXN1 (−747909) 87.34 1.29 1.60E-07 87.39 1.26 6.86E-05 87.60 1.24 2.78E-04 86.98 1.04 5.79E-03
Table 2. Sites characterized by significant changes in DNA methylation on post-operative day 1 compared to 
baseline. Shown for each DMP are the genomic location (hg19) and genic annotation derived using GREAT42. 
Association statistics are presented across all patients, and separately for each surgery type. DMP = differentially 
methylated positions. BL = baseline. DNAm = DNA methylation.
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threshold (P < 5.0E-05) (Supplementary Fig. S11 and Supplementary Table S10). The top-ranked DMP at POD4/7 
(cg26344619), which is significantly hypomethylated following surgery (DNA methylation change = −5.49%, 
P = 1.13E-13), is located within the first intron of FLVCR2 on chromosome 14, a gene encoding a transmembrane 
protein involved in heme and calcium transport27,28. The top-ranked DMR at POD4/7 spans ten hypermethylated 
Figure 3. Differentially methylated regions (DMRs) associated with major surgery. (A) A DMR on 
chromosome 7 annotated to the promoter region of PON3 which was hypomethylated (Sidak-corrected 
P = 1.43E-04) at POD1. (B) A DMR on chromosome 22 within KIAA0930 which was hypermethylated (Sidak-
corrected P = 3.39E-17) at POD4/7. −log10(P) values and effect sizes (%, average DNA methylation difference) 
are shown as red circles and blue diamonds, respectively.
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DMPs Position
GREAT 
annotation
Surgery type
All (n = 30) Colorectal (n = 11) Hip Elective (n = 10) Hip Fracture (n = 9)
BL 
DNAm 
(%)
DNAm 
change 
(%) P value
BL 
DNAm 
(%)
DNAm 
change 
(%) P value
BL 
DNAm 
(%)
DNAm 
change 
(%) P value
BL 
DNAm 
(%)
DNAm 
change 
(%) P value
cg26344619 chr14:76046018
FLVCR2 
(+1079), 
C14orf1 
(+81519)
59.43 −5.49 1.13E-13 58.95 −4.12 3.12E-07 61.69 −6.69 1.07E-10 57.52 −4.73 1.12E-07
cg08975529 chr11:70309722
CTTN 
(+65111), 
SHANK2 
(+626119)
79.53 3.01 4.19E-10 79.20 2.62 4.05E-05 80.02 3.26 3.55E-06 79.39 3.28 4.85E-06
cg22185977 chr5:1518133
SLC6A3 
(−72591), 
LPCAT1 
(+5942)
57.93 4.42 5.21E-10 57.48 3.24 4.20E-04 61.17 4.02 4.86E-05 54.89 5.22 7.18E-07
cg02500152 chr12:48357316 TMEM106C (−13) 20.07 −3.46 8.13E-10 20.78 −3.44 1.11E-05 19.04 −3.23 6.50E-05 20.35 −3.67 1.43E-05
cg24596116 chr12:68665317
IL22 
(−18037), 
MDM1 
(+60843)
61.35 −4.34 9.30E-10 61.97 −5.04 5.22E-07 61.51 −4.67 6.90E-06 60.42 −3.24 1.48E-03
cg12899248 chr17:15845357 ADORA2B (−2873) 81.72 −4.48 1.14E-09 81.54 −4.02 3.68E-05 82.07 −4.90 4.35E-06 81.56 −4.22 5.87E-05
cg25250414 chr15:75871478 PTPN9 (+146) 7.18 −1.19 2.81E-09 7.13 −1.48 5.64E-07 6.94 −0.90 2.15E-03 7.53 −1.14 1.93E-04
cg03592940 chr2:74153896 DGUOK (−56) 5.42 −0.94 5.57E-09 5.35 −1.02 1.29E-05 5.29 −0.99 4.66E-05 5.65 −0.95 1.34E-04
cg19223782 chr11:503807
RNH1 
(+3013), 
PTDSS2 
(+53528)
66.64 3.57 1.51E-08 66.71 2.85 5.22E-04 68.21 4.42 2.87E-06 64.82 2.80 1.51E-03
cg12611488 chr1:2169282
RER1 
(−153931), 
SKI (+9149)
82.79 3.40 1.64E-08 83.20 2.72 1.21E-03 83.08 3.82 3.04E-05 81.98 3.22 4.53E-04
cg07156929 chr6:34856927
TAF11 
(−1109), 
ANKS1A 
(−110)
21.55 −2.35 1.94E-08 22.91 −2.83 1.71E-07 20.28 −1.75 9.82E-04 21.29 −1.83 8.04E-04
cg26426898 chr20:709094
SCRT2 
(−52272), 
C20orf54 
(+40133)
40.41 −2.84 2.00E-08 41.28 −3.61 4.45E-07 39.28 −3.09 2.37E-05 40.60 −1.97 6.06E-03
cg13635184 chr7:148903126
ZNF212 
(−33615), 
ZNF282 
(+10550)
83.84 3.33 2.46E-08 83.26 2.68 6.94E-04 84.11 2.86 6.24E-04 84.24 3.69 3.59E-05
cg00680003 chr6:30523449 PRR3 (−1036) 14.31 −1.74 3.08E-08 14.85 −1.72 1.91E-04 14.12 −1.90 1.03E-04 13.86 −1.66 7.75E-04
cg15133824 chr2:97523823
ANKRD23 
(−14066), 
SEMA4C 
(+11911)
18.61 −2.04 3.20E-08 18.57 −1.73 3.56E-04 18.72 −2.71 5.00E-07 18.52 −1.23 1.58E-02
cg09527731 chr5:132097228
CCNI2 
(+14092), 
SEPT8 
(+15838)
88.08 1.79 3.27E-08 88.10 1.46 1.18E-03 88.26 1.97 5.18E-05 87.86 2.19 1.54E-05
cg01741041 chr7:5567862
FBXL18 
(−14464), 
ACTB 
(+2369)
20.45 2.83 3.89E-08 21.45 2.64 1.32E-04 18.97 2.95 5.69E-05 20.87 2.41 8.10E-04
cg01436362 chr1:229479015 C1orf96 (−328) 4.28 0.65 4.72E-08 4.26 0.70 6.92E-05 4.28 0.59 1.02E-03 4.33 0.62 8.44E-04
cg20120033 chr3:65367695
ADAMTS9 
(−694331), 
MAGI1 
(+656813)
83.51 −2.59 5.02E-08 83.31 −2.20 1.16E-03 83.78 −3.25 1.22E-05 83.46 −2.66 3.32E-04
cg22434506 chr12:6657818
IFFO1 
(+7430), 
GAPDH 
(+14162)
81.19 4.56 5.08E-08 79.68 4.96 1.74E-06 84.11 2.31 2.32E-02 79.78 4.84 1.25E-05
cg07287401 chr10:134054776
DPYSL4 
(+54363), 
STK32C 
(+66700)
87.43 1.77 5.92E-08 86.73 1.36 1.22E-03 87.91 1.48 9.06E-04 87.74 1.86 7.02E-05
Continued
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DMPs Position
GREAT 
annotation
Surgery type
All (n = 30) Colorectal (n = 11) Hip Elective (n = 10) Hip Fracture (n = 9)
BL 
DNAm 
(%)
DNAm 
change 
(%) P value
BL 
DNAm 
(%)
DNAm 
change 
(%) P value
BL 
DNAm 
(%)
DNAm 
change 
(%) P value
BL 
DNAm 
(%)
DNAm 
change 
(%) P value
cg10442358 chr7:100137102 AGFG2 (+269) 7.44 −1.28 6.11E-08 7.76 −1.37 5.07E-05 7.03 −1.10 1.61E-03 7.51 −1.19 8.75E-04
cg02812408 chr6:25153566
LRRC16A 
(−126089), 
CMAHP 
(−15516)
92.99 0.88 6.32E-08 92.88 0.94 7.45E-05 93.07 0.83 7.69E-04 93.05 0.75 2.63E-03
cg19769147 chr14:105860954 TEX22 (−3965) 54.64 3.31 6.64E-08 54.92 3.49 4.20E-05 55.71 2.21 8.38E-03 53.10 3.96 2.11E-05
cg27538352 chrX:49032410
PLP2 
(+4227), 
PRICKLE3 
(+10365)
90.71 1.71 8.33E-08 89.98 2.10 4.40E-07 91.47 1.20 3.42E-03 90.76 1.46 6.11E-04
cg14438885 chr17:59475396 TBX2 (−1860) 20.04 −2.55 8.45E-08 20.98 −2.91 2.14E-06 19.28 −2.55 5.29E-05 19.73 −1.34 3.00E-02
cg19248367 chr11:67141079 CLCF1 (+568) 4.03 −0.66 8.56E-08 4.03 −0.67 1.35E-04 3.84 −0.54 2.97E-03 4.25 −0.82 2.50E-05
cg13286590 chr6:31778018 LSM2 (−3258) 82.11 1.92 9.92E-08 81.82 2.07 6.05E-05 82.15 1.81 7.41E-04 82.42 1.43 8.02E-03
cg04891040 chr16:66399929 CDH5 (−595) 58.61 −5.32 1.03E-07 59.08 −4.12 8.82E-04 61.18 −9.26 7.98E-09 55.17 −3.17 1.39E-02
cg10601171 chr20:61290162
NTSR1 
(−50026), 
SLCO4A1 
(+16366)
66.38 2.81 1.12E-07 67.58 2.24 7.95E-04 65.59 2.43 4.00E-04 65.81 3.29 1.12E-05
cg01678292 chr8:41522873
NKX6-3 
(−17999), 
ANK1 
(+231406)
59.07 5.16 1.16E-07 59.69 2.83 1.31E-02 59.87 5.17 5.18E-05 57.41 6.65 1.43E-06
cg22586221 chr15:78984179
CHRNB4 
(−50593), 
ADAMTS7 
(+119593)
61.25 −3.49 1.18E-07 62.28 −3.38 2.91E-05 61.30 −5.18 8.74E-08 59.93 −1.71 2.70E-02
cg09835486 chr5:112257968 REEP5 (+62) 11.10 −1.79 1.20E-07 10.85 −0.85 5.72E-02 11.21 −2.64 4.30E-07 11.29 −2.02 7.91E-05
cg03963853 chr16:4732369
NUDT16L1 
(−11324), 
MGRN1 
(+57545)
72.46 6.07 1.23E-07 71.96 7.22 1.89E-06 75.66 2.71 4.95E-02 69.52 6.67 2.34E-05
cg04214938 chr2:119496171
EN1 
(+109587), 
INSIG2 
(+650122)
85.04 2.25 1.24E-07 85.62 1.71 1.81E-03 84.88 2.99 4.16E-06 84.51 2.07 6.76E-04
cg20228731 chr7:130646051
MKLN1 
(−366543), 
KLF14 
(−227164)
33.17 −8.92 1.24E-07 30.78 −6.22 4.92E-03 33.54 −8.61 3.50E-04 35.66 −10.93 1.97E-05
cg19089394 chr11:66610747 RCE1 (−135) 3.17 −0.66 1.33E-07 3.36 −0.65 1.90E-04 2.93 −0.59 1.04E-03 3.21 −0.64 6.47E-04
cg14093419 chr7:152591099 ACTR3B (+134249) 86.21 2.02 1.45E-07 86.24 2.06 1.55E-04 86.82 1.69 2.71E-03 85.51 2.21 1.84E-04
cg27380915 chr7:12796513 ARL4A (+70062) 68.30 −4.38 1.46E-07 68.06 −5.83 9.09E-07 70.81 −3.13 4.50E-03 65.82 −3.64 1.46E-03
cg08392069 chr16:2205170 TRAF7 (−628) 3.07 0.48 1.57E-07 2.98 0.49 1.58E-04 3.21 0.45 9.61E-04 3.04 0.38 5.18E-03
cg26912877 chr1:6305344
HES3 
(+1093), 
GPR153 
(+15690)
7.20 −1.26 1.57E-07 7.57 −1.24 1.46E-04 6.83 −0.85 9.37E-03 7.17 −1.45 6.13E-05
cg05625773 chr6:30614796 C6orf136 (−19) 8.74 −1.32 1.84E-07 8.90 −1.34 2.15E-04 8.34 −1.35 3.81E-04 8.97 −1.28 9.41E-04
cg07391756 chr12:132568647
DDX51 
(+60232), 
EP400 
(+134183)
5.75 −0.78 1.84E-07 6.27 −0.94 1.17E-05 5.43 −0.57 8.43E-03 5.48 −0.61 5.78E-03
Table 3. Sites characterized by significant changes in DNA methylation on post-operative day 4 to 7 compared 
to baseline. Shown for each DMP are the genomic location (hg19) and genic annotation derived using GREAT42. 
Association statistics are presented across all patients, and separately for each surgery type. DMP = differentially 
methylated positions. BL = baseline. DNAm = DNA methylation.
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sites on chromosome 22 in the promoter region of KIAA0930 (Sidak-corrected P = 3.39E-17) (Fig. 3B and 
Supplementary Table S7). Functional pathways enriched amongst genes annotated to DMPs at POD4/7 again 
included immune response pathways such as “cellular response to interleukin-6” (P = 3.31E-06) in addition to sev-
eral cytoskeletal pathways including “actomyosin” (P = 6.09E-06) and “filamentous actin” (P = 7.43E-06), which 
play an active role in wound healing and tissue regeneration29,30 (Supplementary Table S11). It is interesting that 
more DMPs were identified at POD4/7 than at POD1; although DNA methylation at only one site (cg26426898 on 
chromosome 20, annotated to SCRT2 and C20orf54) was identified as significantly different (P < 2.0E-07) at both 
POD1 and POD4/7 compared to BL, there was a strong correlation of changes observed at POD1 and POD4/7 
for DMPs identified at both time-points (POD1 DMPs: corr = 0.925, P = 2.86E-05, Fig. 2C; POD4/7 DMPs: corr 
= 0.745, P = 6.00E-09, Fig. 2D) indicating that surgery-induced DNA methylation changes are relatively stable 
until the time of discharge. Together, our results support the notion that the immune-related epigenetic changes 
associated with major surgery occur rapidly and are relatively stable across the post-operative period.
Surgery-associated DNA methylation differences identified by the Illumina 450 K were 
robustly validated using bisulfite-pyrosequencing. We used bisulfite-pyrosequencing to confirm 
surgery-associated changes in DNA methylation at several DMPs, validating the results of our Illumina 450 K 
analyses and finding highly consistent results across platforms. First, we re-quantified DNA methylation at 
cg24501381, one of the top-ranked DMPs from our initial analysis uncorrected for cell-types (average DNA 
methylation change = −4.99%, P = 5.69E-09) that is annotated to CCDC30 on chromosome 1. There was a 
highly significant correlation between Illumina 450 K array and bisulfite-pyrosequencing datasets (P = 1.04E-23, 
Supplementary Fig. S12), with the pyrosequencing data confirming the surgery-associated reduction in DNA 
methylation (average DNA methylation change = −4.37%, P = 8.75E-06, Supplementary Fig. S13). Second, we 
re-quantified DNA methylation at cg26344619, the top-ranked DMP at POD4/7, again finding a highly significant 
correlation between 450 K array and bisulfite-pyrosequencing datasets (P = 5.38E-19, Supplementary Fig. S14), 
with the pyrosequencing data confirming the surgery-associated reduction in DNA methylation (average DNA 
methylation change = −4.90%, P = 7.07E-05, Supplementary Fig. S15).
Heterogeneity in DNA methylation changes between different types of surgery. The DNA 
methylation changes at POD1 and POD4/7 described above are relatively consistent across the three types of 
major surgery (colorectal elective surgery, hip elective surgery, and hip fracture surgery) (Fig. 2A,B). It is, how-
ever, possible that there are unique effects specific to individual surgery-type groups or between emergency and 
elective surgery. The three groups were relatively well-matched for most demographic and surgical parame-
ters; although there were no differences in smoking status, marital status, Charlson’s comorbidity score, Katz 
index, American Society of Anesthesiologists (ASA) classification, or blood loss between surgery types, patients 
undergoing colorectal surgery were younger (P = 1.24E-02) and were exposed to a longer duration of surgery 
(P = 1.13E-02) than the other groups (Table 1). Anaesthesia time was also longer in patients in the colorectal 
surgery group than those undergoing hip elective surgery (P = 1.62E-03). We used an analysis model designed 
to identify changes in DNA methylation that differed between surgery types (see Methods), finding eight 
surgery-type-specific DMPs (P < 2.0E-07) at POD1 (Supplementary Table S12 and Supplementary Fig. S16) and 
eleven at POD4/7 (Supplementary Table S13 and Supplementary Fig. S17). Given the relatively small numbers of 
patients in each of the individual surgery groups, however, these stratified analyses are relatively underpowered 
and should be considered with some caution.
Discussion
In this study we characterized longitudinal changes in DNA methylation in peripheral blood PBMCs collected 
from elderly patients undergoing major surgery. Our primary analyses focused on comparing samples collected 
at baseline to those collected immediately post-operatively and at discharge from hospital. We observed rapid 
changes in DNA methylation following surgery, with widespread differences becoming manifest before the morn-
ing of postoperative day 1. The acute changes in DNA methylation induced by surgery are relatively stable in the 
post-operative period, generally persisting until discharge from hospital.
We found that major surgery is associated with acute changes in DNA methylation at sites annotated to 
immune system genes, reflecting the observed changes in serum-levels of markers associated with surgical 
trauma, including CRP and IL-6, in the same samples. Of note, previous studies have identified changes in DNA 
methylation associated with inflammation and the immune response31,32. This physiological response involves 
dynamic changes in gene regulation, and the acute shifts in DNA methylation observed in our study parallel 
the immunological responses to major surgery that underlie the post-operative recovery7 and which have been 
associated with susceptibility to certain postoperative complications such as nosocomial infection, delirium, and 
cognitive dysfunction4,5. Given the growing need to optimise surgical recovery in our aging population, our 
findings highlight how perioperative molecular approaches might provide insight into the pathophysiology of 
surgical complications, and future work will focus on stratifying individuals to identify methylomic signatures 
of poor outcome33. Although many of the observed changes in DNA methylation are consistent across the three 
types of surgery, there is notable heterogeneity between surgery types at certain loci. These differences may reflect 
different types of surgical procedures, emergency and elective surgery, or even the tissues operated upon, the 
surgical access type and underlying pathology.
This study has several strengths and weaknesses that should be considered when interpreting the results of 
our analyses. First, we implemented a prospective study design, longitudinally sampling individuals before and at 
several time-points after major surgery. The analysis of sequential samples from the same individual that negates 
many of the important confounds that can influence molecular epidemiology as we are using each patient as 
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their own baseline compared to an external reference level from a heterogeneous population and we can control 
for variables such as age, sex and exposure (e.g. to smoking and medication)34. Second, although we isolated 
PBMCs from fresh whole blood, cellular heterogeneity remains an important potential confounder especially 
given the known blood-cell changes known to occur following surgery. Of note, we were able to correct for blood 
cell proportions, albeit only for major cell-types, and show that our derived estimates reflected directly meas-
ured cell-type levels. Our results support the usefulness of cell-correction algorithms in epigenetic epidemiology 
and highlight the importance of adjusting for cell type composition for the epigenetic research in perioperative 
period. Despite this, it is possible that our results reflect shifts in subpopulations of PBMCs as well as by activation 
of specific cell subsets. Furthermore, given the damage to other tissues that invariable take place during surgery, 
it is possible that our results are also confounded by DNA and cellular components from other organs. Third, 
we quantified DNA methylation using the Illumina 450 K array; although this platform interrogates sites anno-
tated to the majority of genes, the actual proportion of sites across the genome interrogated by this technology 
is relatively low, with a predominant focus on Cytosine-guanine dinucleotide (CpG) rich promoter regions. It 
will be important for future studies to explore surgery-induced changes in DNA methylation across regions not 
well-covered by the Illumina 450 K array. Of note, we used bisulfite-Pyrosequencing to validate surgery-induced 
DNA methylation changes at several loci, confirming the robustness of the 450 K array for identifying real DNA 
methylation changes. Fourth, we did not assess changes in gene expression resulting from the methylomic var-
iation induced by surgery, and this should be a focus of future work. However, we did find dramatic changes in 
both CRP and IL-6 levels in serum from the same individuals using ELISA, confirming functional effects on the 
immune system. Although the magnitude of changes in DNA methylation observed were relatively small, they 
are statistically robust and occur at sites annotated to genes with a known role in the immunological response. 
Finally, the inclusion of patients undergoing multiple surgery types enabled us to explore the consistency of DNA 
methylation changes following major surgery. Despite this, however, individual surgery-type groups were rela-
tively small and future work is needed to further interrogate genomic changes specific to each group. Surgery is a 
complex procedure and involves a large combination of factors that could influence DNA methylation including 
the surgical approach (open versus minimally-invasive), differences in anaesthetic techniques used, differences 
in the tissues undergoing surgery, and different rates of complications and compounding factors. Future work in 
larger surgical cohorts will enable us to address these factors.
To our knowledge, this represents the first study to systematically explore acute changes in gene regulation 
following major surgery. We identified acute surgery-associated changes in DNA methylation which are relatively 
stable until discharge from hospital. Taken together, our results highlight the dramatic alterations in gene regula-
tion induced by invasive surgery, primarily reflecting upregulation of the immune system in response to trauma.
Methods
participants and sample collection. Potential participants were identified by clinicians during routine 
clinical practice. Between July 2014 and January 2015, a total of 55 patients undergoing routine/emergency sur-
gery at the Royal Devon & Exeter Hospital (Exeter, UK) were recruited via the Royal Devon and Exeter Tissue 
Bank (RDETB). The ethically approved RDETB (REC ref: 11/SW/0018) was set up to proactively collect and 
store tissue available from routine clinical procedures for studies examining disease specific biomarkers and is 
facilitated through the NIHR Exeter Clinical Research Facility (ECRF) https://exetercrfnihr.org/about/rde-tissue-
bank/. This study was conducted in accordance with the 1964 Helsinki Declaration. Patients with known demen-
tia, cognitive decline (defined as <9/10 points on the Abbreviated Mental Test35), delirium before surgery, early 
discharge within 3 days after surgery were excluded from participating in the study. Written informed consent 
was obtained from all participants. Pre-operatively, patients were assessed using the Katz index36, the Charlson’s 
comorbidity score37 and the ASA classification, with the absence of delirium was assessed using the Confusion 
Assessment Method38. Peripheral whole blood samples were obtained at three time points: 1) immediately before 
surgery at baseline (“BL”), 2) in the morning on post-operation day 1 (“POD1”) and 3) on day 4–7 immediately 
prior to discharge (“POD4/7”). Whole blood was taken by a trained research nurse in addition to clinical exam-
ination and samples were immediately transferred to the research team for isolation of PBMCs. Out of the 55 
patients recruited to the study, a complete set of biological and clinical samples were collected from 30 patients. 
A number of patients were excluded; unstable/severe clinical condition (n = 2), cancelled surgery (n = 4), failed 
sample collection (n = 2), history of delirium (n = 2), or early discharge and a failure to collect three blood sam-
ples (n = 15). An overview of the patients included in our final analysis dataset is given in Supplementary Fig. S1.
IL-6, CRP, and blood component measurements. Serum was collected from fresh blood samples by 
centrifugation at 1,600 × g at room temperature for 20 minutes and stored at −80 °C until use. Serum IL-6 levels 
were measured using the Quantikine Enzyme Linked Immuno-Sorbent Assay Human IL-6 Kit (R&D Systems, 
Minneapolis, Minnesota, United States) following the manufacturers standard protocol. Each experiment was 
performed in duplicate and calibrated using standards. Serum levels of CRP and other blood components were 
measured in the hospital clinical chemistry laboratory. Laboratory-derived data measured within 3 days before 
surgery were accepted as baseline.
Genome-wide DNA methylation profiling. PBMCs were isolated from fresh whole blood, 15 minutes to 
2 hours after collection, using Vacutainer CPT Mononuclear Cell Preparation Tubes (Becton Dickinson, Franklin 
Lakes, New Jersey, United States). Ficoll-separated PBMCs were centrifuged at 1,600 × g at room temperature 
for 20 minutes, and then washed twice with 5 ml PBS. Isolated PBMCs were resuspended in RNAprotect cell 
reagent (Qiagen, Redwood City, California, United States) and stored at −80 °C. Genomic DNA was extracted 
using the AllPrep DNA/RNA minikit (Qiagen) and bisulfite converted using the EZ-96 DNA Methylation-Gold 
kit (Zymo research, Irvine, California, United States) following the manufacture’s standard protocol. Aliquoted 
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bisulfite converted DNA was amplified with bisulfite specific primers to confirm conversion efficiency prior to 
array analysis. Genome-wide DNA methylation was profiled using the Illumina Infinium HumanMethylation450 
BeadChip (Illumina Inc, San Diego, California, United States) (“450 K array”) and scanned on an Illumina iScan. 
Our stringent quality control pipeline included the following steps: (1) checking methylated and unmethylated 
signal intensities; (2) using the 10 control probes to ensure the bisulfite conversion was successful, excluding any 
samples with median <90; (3) multidimensional scaling of sites on X and Y chromosomes separately to confirm 
reported gender; (4) comparison of genotype data for up to 65 single nucleotide polymorphism (SNP) probes on 
450 K array; and (5) use of the pfilter() function from the wateRmelon package to exclude samples with >1% of 
probes with detection P value > 0.05 and probes with >1% of samples with detection P value > 0.05. The data was 
subsequently normalized using the dasen function in the wateRmelon package for a combination of background 
adjustment and between-array quantile normalization39. Probes with non-specific sequences and those contain-
ing common (Minor allele frequency >5%) single nucleotide polymorphism probes in European population were 
removed40 leaving 427,353 probes for analysis.
Bisulfite-pyrosequencing. Bisulfite-pyrosequencing was performed to validate DNA methylation data 
from the Illumina 450 K array for two CpG sites using specific primers (Supplementary Table S14) designed using 
PyroMark Assay Design software 2.0 (Qiagen). DNA methylation was quantified from intensities captured in the 
PyroMark Q24 pyrosequencer (Qiagen) based on duplicated bisulfite polymerase chain reaction amplification.
Statistical analyses. All statistical analyses were performed in the R statistical environment (version, 3.3.2). 
Surgery-induced DNA methylation across the genome was first examined using paired t-test for 427,353 DNA 
methylation sites included in our dataset following QC. We then used a multi-level linear regression model fitted 
for each DNA methylation site with fixed effects for estimated cell counts (derived using the Epigenetic Clock 
Software21: https://labs.genetics.ucla.edu/horvath/dnamage/), age, sex, and processing batch and a random effect 
for individual using the lme4 R package41. For Illumina array analyses we used a threshold of P < 2.0E-7 for 
genome wide significance and P < 5.0E-05 to select probes for GO pathway analyses. Demographic data were 
tested using analysis of variance (ANOVA). Laboratory-derived blood data alterations following surgery were 
tested using a paired t-test. CRP levels were assessed using a two-tailed t-test because of decreased sample size in 
sequential measures.
Ethics approval and consent to participate. This study was approved by the RDETB Steering 
Committee under the terms of the overall RDETB ethical approval (REC ref: 11/SW/0018). All participants 
provided written informed consent for participation. This project was conducted in accordance with the 1964 
Helsinki Declaration.
Data availability
Raw data are available to download from the Gene Expression Omnibus (GEO, https://www.ncbi.nlm.nih.gov/
geo/) and analysis scripts are available from the authors on request.
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